Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Medroxyprogesterone"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringMedroxyprogesterone acetate (MPA)
brandStringProvera (oral), Depo-Provera (IM contraceptive), Depo-SubQ Provera 104 (SC)
structureFile
classesList of String, delimiter: ,[[:Category:Progestogens|Progestin (synthetic progestogen)]] [[:Category:Hormonal_contraceptives|Hormonal contraceptive (Depo)]] [[:Category:Sex_hormones|Sex hormone]]
mechanismString
usesString'"`UNIQ--vote-00000F1B-QINU`"', '"`UNIQ--vote-00000F1C-QINU`"', '"`UNIQ--vote-00000F1D-QINU`"', '"`UNIQ--vote-00000F1E-QINU`"', '"`UNIQ--vote-00000F1F-QINU`"'
starting_doseStringContraception: Depo-Provera 150 mg IM every 13 weeks; Depo-SubQ 104 mg SC every 12-13 weeks; oral cycling: 5-10 mg PO daily ×5-10 days for amenorrhea
preparationsString2.5, 5, 10 mg oral tablets; Depo-Provera 150 mg/mL IM; Depo-SubQ Provera 104 mg/0.65 mL
fda_maxStringIndication-specific
pill_idText
routesList of String, delimiter: ,Oral IM SC
onsetStringContraceptive within 24 hours if given in first 5 days of cycle; otherwise backup for 7 days
durationStringDepot IM 13 weeks (designed); often persists longer
halflifeString~50 days (Depo-Provera; long depot release)'"`UNIQ--ref-00000F20-QINU`"'
bioavailabilityStringOral ~90%; depot IM essentially 100% over the dosing interval'"`UNIQ--ref-00000F21-QINU`"'
pregnancyStringContraindicated in known pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup>
legalString[[USLegal:Prescription only|Rx-only]] in US. Carries a '''Boxed Warning''' for bone mineral density loss with prolonged use (≥2 years; partially reversible after discontinuation)'"`UNIQ--ref-00000F22-QINU`"'